Patents Assigned to J.B. Chemical and Pharmaceuticals Limited
-
Patent number: 9180124Abstract: Disclosed is nicotine containing solid oral transmucosal dosage forms containing a therapeutically effective amount of nicotine polacrilex, citric acid monohydrate, sucrose and liquid glucose. The dosage form is preferably in the form of lozenge.Type: GrantFiled: December 1, 2010Date of Patent: November 10, 2015Assignee: J. B. Chemicals and Pharmaceuticals LimitedInventors: Bharat Pravinchandra Mehta, Rajen Dhirubhai Shah, Manoj Kantilal Patel, Parmeshwar B. Bang
-
Publication number: 20120244104Abstract: Disclosed is nicotine containing solid oral transmucosal dosage forms containing a therapeutically effective amount of nicotine polacrilex, citric acid monohydrate, sucrose and liquid glucose. The dosage form is preferably in the form of lozenge.Type: ApplicationFiled: December 1, 2010Publication date: September 27, 2012Applicant: J. B. Chemicals and Pharmaceuticals LimitedInventors: Bharat Pravinchandra Mehta, Rajen Dhirubhai Shah, Manoj Kantilal Patel, Parmeshwar B. Bang
-
Publication number: 20030228376Abstract: A pharmaceutical composition for topical application and manufacturing process thereof for treatment of microbial and mycotic infections caused by aerobic and anaerobic microorganisms is provided comprising metronidazole and Povidone-Iodine, in effective amounts. Such a composition can be administered topically to patients in need thereof in various pharmaceutical dosage forms.Type: ApplicationFiled: June 6, 2002Publication date: December 11, 2003Applicant: J.B. Chemicals & Pharmaceuticals LimitedInventors: Shirish Bhagwanlal Mody, Madhukant Mansukhlal Doshi, Mild Dattatraya Joshi
-
Publication number: 20030064101Abstract: The present invention provides a novel floating osmotic device that is capable of delivering a first active agent in an outer coat immediately followed by continuous controlled delivery of second active agent from the osmotic core while the dosage form floats in the fluid of the environment. The floating osmotic device has of a compressed core containing active agent, a semipermeable membrane surrounding the core that is permeable to surrounding fluid and impermeable to the active agent, and an outer coating of a gas generating ingredient, a gelling agent, and a second active agent. Particular embodiments of the invention provide floating osmotic devices in which all two active agents are similar or dissimilar.Type: ApplicationFiled: November 6, 2001Publication date: April 3, 2003Applicant: J.B. Chemicals & Pharmaceuticals LimitedInventors: Bharat Pravinchandra Mehta, Madhukant Mansukhlal Doshi, Milind Dattatraya Joshi
-
Patent number: 6403629Abstract: A class of compounds particularly diaryl pyrazole of general formulas 1 and 2 where R and R′ represents alkyl, hydrogen, halogens, haloalkyl, cyano, nitro, formyl, carboxyl, alkoxycarbonyl, carboxyalkyl, alkoxycarbonylalkyl, hydroxyalkyl, alkylthio, alkylsulfinyl, alkylsulphonyl, N- alkylsulfamyl, N-arylsulfamyl, cyanoamido, amino, amidino, N-monoalkylamido, N-monoarylamido, N,N-dialkylamido, N-alkyl-N-arylamido, N,N-dialkylsulfamyl with the alkyl, or alkyl part of each such group containing 1-3 carbon atoms or mixtures thereof optionally their salts when they exist, and preparation thereof. The compounds of the present invention are antiinflammatory, antipyretic, antirheumatic, antiosteoarthritic agents with antibacterial activity. The particular class of compounds is given below (Formula 1 and Formula 2).Type: GrantFiled: March 15, 2001Date of Patent: June 11, 2002Assignee: J.B. Chemical and Pharmaceuticals LimitedInventors: Atul Anant Shrikhande, Madhukant Mansukhlal Doshi, Shirish Bhagwanlal Mody
-
Publication number: 20010047023Abstract: A class of compounds particularly diaryl pyrazole of general formulas 1 and 2 where R and R′ represents alkyl, hydrogen, halogens, haloalkyl, cyano, nitro, formyl, carboxyl, alkoxycarbonyl, carboxyalkyl, alkoxycarbonylalkyl, hydroxyalkyl, alkylthio, alkylsulfinyl, alkylsulphonyl, N- alkylsulfamyl, N-arylsulfamyl, cyanoamido, amino, amidino, N-monoalkylamido, N-monoarylamido, N,N-dialkylamido, N-alkyl-N-arylamido, N, N-dialkylsulfamyl with the alkyl, or alkyl part of each such group containing 1-3 carbon atoms or mixtures thereof optionally their salts when they exist, and preparation thereof.Type: ApplicationFiled: March 15, 2001Publication date: November 29, 2001Applicant: J.B. Chemicals & Pharmaceuticals LimitedInventors: Atul Anant Shrikhande, Madhukant Mansukhlal Doshi, Shirish Bhagwanlal Mody
-
Patent number: 5853756Abstract: The present invention provides oral formulations of Ranitidine Hydrochloride in the form of coated tablets and capsules which produce controlled or regulated dissolution and release at a fairly uniform rate over long periods--as long as 12 to 24 hours--to maintain Ranitidine at desired levels above the MEC.Type: GrantFiled: September 1, 1995Date of Patent: December 29, 1998Assignee: J. B. Chemicals & Pharmaceuticals LimitedInventors: Shri Shirish Bhagwanlal Mody, Madhukant Mansukhlal Doshi, Milind Dattatraya Joshi